Teva amplía la emisión de pagarés de sostenibilidad a $5.000 millones
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Teva Pharmaceutical: Past Behind And A Promising 2023 (NYSE:TEVA) | Seeking Alpha
Teva Announces $1.5 Billion Debt Tender Offer | Ctech
Teva Reports Third Quarter 2020 Financial Results | Business Wire
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? | Nasdaq
Sergio Martin Calvo - Sales Support Specialist - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical Industries Stock Is Estimated To Be Fairly Valued
Teva to shut Ashdod plant within year, with loss of 175 jobs | The Times of Israel
Can Teva's Debt Repayment Plan Deleverage Its Balance Sheet?
Teva's Working With Evercore to Review Debt Options - Bloomberg
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Teva announces debt recycling measures - Globes
TEVA | Market Realist
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
Why You Should Still Buy Teva (NYSE:TEVA) | Seeking Alpha
Drugmaker Teva looks to sell Medis business to help cut debt | Reuters
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Teva Stock Offers Maximum Optimism For Investors (NYSE:TEVA) | Seeking Alpha
Idea of the Week: Teva Pharmaceutical—The Top Leader in Generic Drugs | Bondsupermart
DEF 14A
